VIEMED HEALTHCARE INC
For the period ended Dec 31, 2024. Filed Mar 10, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 10, 2025
VMD$8.98+0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Income and Comprehensive Income
VIEMED HEALTHCARE, INC.CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
(Expressed in thousands of U.S. Dollars, except share and per share amounts)
| Year Ended December 31, | ||||
|---|---|---|---|---|
| Note | 2024 | 2023 | 2022 | |
| Revenue | 2 | $224,257 | $183,008 | $138,832 |
| Cost of revenue | 91,054 | 70,225 | 54,152 | |
| Gross profit | $133,203 | $112,783 | $84,680 | |
| Operating expenses | ||||
| Selling, general and administrative | 106,199 | 87,884 | 68,161 | |
| Research and development | 3,068 | 2,782 | 2,696 | |
| Stock-based compensation | 8 | 6,285 | 5,849 | 5,202 |
| Depreciation and amortization | 1,483 | 1,391 | 1,012 | |
| Loss (gain) on disposal of property and equipment | (1,905) | 645 | 346 | |
| Other expense (income), net | 173 | (98) | (989) | |
| Income from operations | $17,900 | $14,330 | $8,252 | |
| Non-operating income and expenses | ||||
| Income (expense) from investments | (954) | 485 | 935 | |
| Interest expense, net | 6 | (776) | (424) | (197) |
| Net income before taxes | 16,170 | 14,391 | 8,990 | |
| Provision for income taxes | 10 | 4,761 | 4,148 | 2,768 |
| Net income | $11,409 | $10,243 | $6,222 | |
| Net income attributable to noncontrolling interest | 144 | — | — | |
| Net income attributable to Viemed Healthcare, Inc. | $11,265 | $10,243 | $6,222 | |
| Other comprehensive income | ||||
| Change in unrealized gain on derivative instruments, net of tax | — | — | 278 | |
| Other comprehensive income | $— | $— | $278 | |
| Comprehensive income | $11,265 | $10,243 | $6,500 | |
| Net income per share | ||||
| Basic | 11 | $0.29 | $0.27 | $0.16 |
| Diluted | 11 | $0.28 | $0.25 | $0.16 |
| Weighted average number of common shares outstanding: | ||||
| Basic | 11 | 38,754,893 | 38,354,071 | 38,655,403 |
| Diluted | 11 | 40,805,085 | 40,378,922 | 39,807,434 |
| See accompanying notes to the consolidated financial statements | |
|---|---|
| Page | F-5 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.